BCM
OM icon

BML Capital Management’s Outset Medical OM Stock Holding History

BML Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.3M Buy
1,902,201
+1,359,021
+250% +$5.57M 4.69% 5
2025
Q4 		$2.02M Buy
+543,180
New +$4.66M 1.74% 10

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BML Capital Management's OM Position: Q1 2026 in Review

BML Capital Management increased its Outset Medical (OM) stake by 250% in Q1 2026, buying an estimated $5.57M and bringing the position to 1,902,201 shares worth $7.3M. The position accounts for 4.69% of the portfolio, ranked #5.

BML Capital Management first reported a position in OM in Q4 2025 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • BML Capital Management held 1,902,201 shares of Outset Medical worth $7.3M as of Q1 2026.
  • BML Capital Management bought 1,359,021 Outset Medical shares in Q1 2026, an estimated $5.57M.
  • Outset Medical made up 4.69% of BML Capital Management's portfolio in Q1 2026, its #5 holding.
  • BML Capital Management first reported a position in Outset Medical in Q4 2025 and has held it in 2 quarters since.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on BML Capital Management's 13F filing for Q1 2026, filed 6 May 2026.